Brand Name

Vermox

Generic Name
Mebendazole
View Brand Information
FDA approval date: October 20, 2016
Classification: Anthelmintic
Form: Tablet

What is Vermox (Mebendazole)?

VERMOX™ CHEWABLE is indicated for the treatment of patients one year of age and older with gastrointestinal infections caused by Ascaris lumbricoides and Trichuris trichiura . VERMOX™ CHEWABLE is an anthelmintic indicated for the treatment of patients one year of age and older with gastrointestinal infections caused by: Ascaris lumbricoides and Trichuris trichiura .

Approved To Treat

Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

Clinical Study to Evaluate the Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine

Summary: To evaluate the possible efficacy and safety of mebendazole in patients with ulcerative colitis treated with mesalamine

Clinical Study Evaluating Mebendazole as Adjuvant Therapy in Patients With Colorectal Cancer

Summary: mebendazole treating colon cancer